MedPath

A Study to Evaluate EDP 938 Regimens in Children With RSV

Phase 2
Completed
Conditions
Respiratory Syncytial Virus (RSV)
Interventions
Drug: Placebo
Drug: EDP-938
Registration Number
NCT04816721
Lead Sponsor
Enanta Pharmaceuticals, Inc
Brief Summary

A 2-part study to evaluate the safety, pharmacokinetics and efficacy of EDP-938 in children with RSV infection.

Detailed Description

This is a randomized, double-blind, dose ranging, placebo-controlled study in respiratory syncytial virus (RSV) among hospitalized and non-hospitalized children aged from 28 days to 36 months, assessing the safety, tolerability, pharmacokinetics, clinical outcome and antiviral activity of a 5 day treatment with EDP-938.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria
  • Male or female who is either ≥6 months to ≤36 months (for Age Group 1) or ≥28 days to <6 months (for Age Group 2), defined at the time of randomization. Subjects in Age Group 2 must have been born ≥29 weeks of gestation to be eligible.
  • Subjects diagnosed with RSV infection
  • Subjects with signs of an acute respiratory illness with onset ≤7 days for Part 1 and ≤5 days for Part 2 before the time of signing the ICF
  • In the Investigator's opinion, the subject's caregiver understands and is able to comply with protocol requirements, instructions, and protocol-stated restrictions, and the subject is likely to complete the study as planned
Read More
Exclusion Criteria
  • Use of or anticipated need for invasive mechanical ventilation, cardiopulmonary bypass, hemodialysis, or extracorporeal membrane oxygenation; or subjects who are not expected to survive the current illness
  • Underlying immune deficiency, (e.g., from confirmed human immunodeficiency virus infection or use of an immunosuppressive medication except immunoglobulin A deficiency)
  • Receipt of (within 12 months before Screening) or on a waiting list for a bone marrow, stem cell, or solid organ transplant, or who received radiation or chemotherapy (within 12 months before screening)
  • Receiving chronic oxygen therapy at home before admission
  • Subjects whose mother received an investigational RSV vaccination while pregnant with the subject if they were born at term (≥37 weeks of gestation) and are less than 12 months of age
  • In Part 2, subjects dosed with an investigational or approved medication that is intended to prevent or treat RSV infection within the following times before the first dose of study drug: ribavirin 35 days; palivizumab 100 days; nirsevimab 350 days; other RSV-specific monoclonal antibody 5 half-lives of the specific antibody; RSV vaccines 12 months.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboMatching placebo, orally, once daily for 5 days
EDP-938EDP-938EDP-938, oral suspension, once daily for 5 days
Primary Outcome Measures
NameTimeMethod
Daily change from baseline in RSV sheddingUp to 14 Days
AUC of EDP-938 (Part 1)Up to 5 days
Predose concentration of EDP-938 (Part 1)Up to 5 days
Safety and tolerability of EDP-938 compared to placebo measured by adverse events (Part 1)Up to 29 Days
Secondary Outcome Measures
NameTimeMethod
Predose concentration of EDP-938 (Part 2)Up to 5 Days
Daily change in RSV shedding (Part 1)Up to 14 Days
Proportion of subjects with undetectable level of RSV RNA viral load (Part 1 and Part 2)Up to 14 Days
Time to RSV RNA viral load being undetectable (Part 1 and Part 2)Up to 14 Days
Proportion of hospitalized subjects requiring oxygen supplementation or have an increased oxygen requirementUp to 29 Days
Time to use of oxygen for hospitalized subjects who are not receiving oxygen at the time they receive the first dose of study drug (Part 2)Up to 29 Days
Safety and tolerability of EDP-938 compared to placebo measured by adverse events (Part 2)Up to 29 Days
AUC for RSV RNA viral load (Part 1 and Part 2)Up to 14 Days
AUC of EDP-938 (Part 2)Up to 5 Days
Time to discharge for hospitalized subjects (Part 2)Up to 29 Days

Trial Locations

Locations (78)

Memorial Care Miller Children's and Women's Hospital

🇺🇸

Long Beach, California, United States

University of California Los Angeles (UCLA)

🇺🇸

Los Angeles, California, United States

UC Davis

🇺🇸

Sacramento, California, United States

Nemours Children's Hospital

🇺🇸

Orlando, Florida, United States

South Tampa Center for Advanced Healthcare

🇺🇸

Tampa, Florida, United States

Rexburg Pediatrics

🇺🇸

Rexburg, Idaho, United States

Ann & Robert H. Lurie Children's Hospital of Chicago

🇺🇸

Chicago, Illinois, United States

Norton Children's Research Institute

🇺🇸

Louisville, Kentucky, United States

MedPharmics - Lafayette

🇺🇸

Lafayette, Louisiana, United States

LSU Health

🇺🇸

Shreveport, Louisiana, United States

Willis-Knighton Health System

🇺🇸

Shreveport, Louisiana, United States

Boston Children's Hospital - Division of Adolescent/Youth Adult Medicine

🇺🇸

Boston, Massachusetts, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Le Bonheur Children's Hospital

🇺🇸

Memphis, Tennessee, United States

Driscoll Children's Hospital

🇺🇸

Corpus Christi, Texas, United States

Children's Health Specialty Center Dallas Campus

🇺🇸

Dallas, Texas, United States

Clinica del Niño y la Familia

🇦🇷

Mar Del Plata, Buenos Aires, Argentina

Hospital Interzonal Dr Jose Penna

🇦🇷

Bahía Blanca, Argentina

Clínica Privada del Sol

🇦🇷

Buenos Aires, Argentina

Instituto Medico Rio Cuarto

🇦🇷

Río Cuarto, Argentina

Clinica Central S.A

🇦🇷

Villa Regina, Argentina

Sydney Children's Hospital - Randwick

🇦🇺

Randwick, New South Wales, Australia

The Children's Hospital at Westmead

🇦🇺

Westmead, New South Wales, Australia

Gold Coast University Hospital

🇦🇺

Southport, Australia

Instituto Méderi de Pesquisa e Saúde

🇧🇷

Passo Fundo, Rio Grande Do Sul, Brazil

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Irmandade da Santa Casa de Misericórdia Hospital - Porto Alegre

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Universidade Federal do Paraná - Hospital de Clínicas

🇧🇷

Curitiba, Brazil

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

🇧🇷

Ribeirão Preto, Brazil

Universitätsklinikum Gießen und Marburg - Gießen

🇩🇪

Marburg, Bundesland, Germany

Universitätsklinikum Erlangen

🇩🇪

Erlangen, Germany

Asklepios Klinik Sankt Augustin

🇩🇪

Sankt Augustin, Germany

Soroka University Medical Center

🇮🇱

Be'er Sheva, Israel

Rambam Health Care

🇮🇱

Haifa, Israel

Carmel Medical Center

🇮🇱

Haifa, Israel

Hadassah University Hospital Mount Scopu

🇮🇱

Jerusalem, Israel

Schneider Children's Medical Center Of Israel

🇮🇱

Petach Tikva, Israel

Nowon Eulji Medical Center, Eulji University

🇰🇷

Seoul, Korea, Republic of

Kyung Hee University Hospital

🇰🇷

Seoul, Korea, Republic of

Inje University Sanggye Paik Hospital

🇰🇷

Seoul, Korea, Republic of

Panamerican Clinical Research Mexico - Guadalajara

🇲🇽

Guadalajara, Prados, Mexico

Instituto Nacional de Pediatría

🇲🇽

Mexico City, Mexico

Hospital Infantil De Mexico Federico Gomez

🇲🇽

Mexico City, Mexico

Karla Adriana Espinosa Bautista

🇲🇽

Mexico City, Mexico

IESCI Clinical Research

🇲🇽

Monterrey, Mexico

PanAmerican Clinical Research

🇲🇽

Querétaro, Mexico

SMIQ S de R.L de C.V

🇲🇽

Querétaro, Mexico

Wellington Regional Hospital

🇳🇿

Newtown, Wellington, New Zealand

IN-VIVO Bydgoszcz

🇵🇱

Bydgoszcz, Poland

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi

🇵🇱

Łódź, Poland

Spital Clinic de Urgenta Pentru Copii Brasov

🇷🇴

Braşov, Brașov, Romania

Spitalul Clinic Judetean De Urgenta Târgu Mureș

🇷🇴

Târgu-Mureş, Târgu Mureș, Romania

Institutul National pentru Sanatatea Mamei si Copilului "Alessandrescu-Rusescu"

🇷🇴

Bucharest, Romania

Life Westville Hospital

🇿🇦

Westville, Durban, South Africa

Rahima Moosa Mother and Child Hospital

🇿🇦

Johannesburg, South Africa

Wits Clinical Research

🇿🇦

Soweto, South Africa

Hospital Germans Trias i Pujol

🇪🇸

Barcelona, Spain

Hospital Universitario Arnau de Vilanova

🇪🇸

Lleida, Spain

Hospital Clínico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Universitario Fundación Jiménez Díaz

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital Universitario Puerta de Hierro - Majadahonda

🇪🇸

Madrid, Spain

Hospital Universitario Quirónsalud Madrid

🇪🇸

Madrid, Spain

Hospital Universitario Severo Ochoa

🇪🇸

Madrid, Spain

Unidad de Ensayos Clínicos Pediátricos

🇪🇸

Madrid, Spain

Hospital Regional Universitario de Málaga

🇪🇸

Málaga, Spain

Hospital Clínico Universitario de Santiago

🇪🇸

Santiago De Compostela, Spain

Hospital Universitario Joan XXIII de Tarragona

🇪🇸

Tarragona, Spain

National Taiwan University Hospital

🇨🇳

Taipei city, Taipei, Taiwan

Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation

🇨🇳

Taoyuan City, Taoyuan, Taiwan

Hsinchu Mackay Memorial Hospital

🇨🇳

Hsinchu, Taiwan

Chang Gung Memorial Hospital - Kaohsiung Branch

🇨🇳

Kaohsiung, Taiwan

Chung Shan Medical University Hospital

🇨🇳

Taichung, Taiwan

Taipei Mackay Memorial Hospital

🇨🇳

Taipei, Taiwan

Nottingham University Hospitals NHS Trust

🇬🇧

Nottingham, Nottinghamshire, United Kingdom

St. George's University Hospitals NHS Foundation Trust

🇬🇧

London, United Kingdom

Sheffield Children's NHS Foundation Trust

🇬🇧

Sheffield, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath